Researchers at Johns Hopkins Want to Know How Psychedelics Changed Your Life
They’re conducting pioneering research into the therapeutic potential of tripping.
Researchers at Johns Hopkins University want to know if you’ve ever tripped so hard it totally changed your outlook on life. In a new anonymous survey, the study asks psychonauts to share psychological insights they’ve gained after taking substances like psilocybin mushrooms, DMT and LSD.
For the purposes of this study, researchers define “psychological insight” quite broadly and the questions are largely open-ended. Participants can discuss personal changes they’ve noticed in their own behavior, relationships or mystical experiences which resulted in some perspective-changing revelations.
The study aims to measure something known to psychedelics researchers as quantum change or an experience that, when combined with psychedelics, can result in profound change in a subject’s outlook.
“The importance of this quantum change model is incredible as it will expand our current framework of psychedelic therapy models and help provide evidence that mystical and insightful experiences that are brought about by psychedelics might explain why they are so powerfully associated with positive behavioral, emotional, and cognitive change,” Alan Davis, a co-researcher at Johns Hopkins, told Motherboard.
In March, Johns Hopkins launched a similar survey asking if those who have taken DMT have ever had an experience or encounters with “entities” as well as near-death experiences.
For several years now, Johns Hopkins has been at the forefront of psychedelic research, partnering with organizations like the Beckley Foundation and MAPS to study the effects of these mind-altering substances. Researchers at the university have studied everything from generic medicinal uses for psychedelics in psychotherapy to the mystical experiences people often report having while tripping.
While recent studies have significantly advanced our knowledge of these substances with the use of modern technology like fMRI brain scanning, a persistent issue with the study of psychedelics remains the small sample sizes. The current Johns Hopkins survey hopes to capture a larger sample of psychedelic users whose experiences will be presented to the scientific community.
Participants in the survey must be at least 18 years or older who have taken substances such as psilocybin mushrooms, LSD, ayahuasca, mescaline, N,N-DMT, 5-MeO-DMT, peyote, 4-Acetoxy-DMT, Salvia, Ibogaine or any other substance that would be considered a classic psychedelic.
For those who want to participate, the survey can be found here.